溶瘤性牛痘病毒的免疫调节特性及其在治疗学中的意义。
The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.
机构信息
Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, 1600 SW Archer Rd, P.O. box 100266, Gainesville, FL 32610, USA.
出版信息
Microbes Infect. 2010 Dec;12(14-15):1144-52. doi: 10.1016/j.micinf.2010.08.012. Epub 2010 Sep 9.
Abstract
Myxoma virus (MYXV) is a poxvirus with a strict rabbit-specific host-tropism for pathogenesis. The immunoregulatory factors encoded by MYXV can suppress some functions of immune effectors from other species. We review their mechanisms of action, implications in therapeutics and the potential to improve MYXV as an oncolytic agent in humans.
摘要
粘液瘤病毒（MYXV）是一种严格的兔源痘病毒，对发病机制具有特异性宿主趋向性。MYXV 编码的免疫调节因子可以抑制来自其他物种的免疫效应物的某些功能。我们综述了它们的作用机制、在治疗中的意义以及提高 MYXV 作为人类溶瘤剂的潜力。
相似文献
1
The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.溶瘤性牛痘病毒的免疫调节特性及其在治疗学中的意义。
Microbes Infect. 2010 Dec;12(14-15):1144-52. doi: 10.1016/j.micinf.2010.08.012. Epub 2010 Sep 9.
2
The current status and future directions of myxoma virus, a master in immune evasion.黏液瘤病毒：免疫逃避大师的现状与未来方向
Vet Res. 2011 Jun 9;42(1):76. doi: 10.1186/1297-9716-42-76.
3
Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.表达美洲红点鲑疱疹病毒 orfC 的重组兔粘液瘤病毒在兔子中减毒。
Viruses. 2020 May 8;12(5):517. doi: 10.3390/v12050517.
4
RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells.RNA 解旋酶 A/DHX9 形成独特的细胞质抗病毒颗粒，限制溶瘤性兔病毒性出血热病毒在人癌细胞中的复制。
J Virol. 2021 Jun 24;95(14):e0015121. doi: 10.1128/JVI.00151-21.
5
Genetic Variability of Myxoma Virus Genomes.黏液瘤病毒基因组的遗传变异性
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.01570-16. Print 2017 Feb 15.
6
Oncolytic myxoma virus: the path to clinic.溶瘤性牛痘病毒：走向临床的道路。
Vaccine. 2013 Sep 6;31(39):4252-8. doi: 10.1016/j.vaccine.2013.05.056. Epub 2013 May 29.
7
Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells.黏液瘤病毒可抑制活化T淋巴细胞的增殖，但能使溶瘤病毒转移至癌细胞。
Blood. 2015 Jun 11;125(24):3778-88. doi: 10.1182/blood-2014-07-587329. Epub 2015 Apr 22.
8
Methods for the Construction of Recombinant Oncolytic Myxoma Viruses.重组溶瘤性兔病毒性出血症病毒的构建方法。
Methods Mol Biol. 2021;2225:63-75. doi: 10.1007/978-1-0716-1012-1_4.
9
Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.促进胶质瘤对溶瘤性黏液瘤病毒有效治疗产生抗性的细胞因子。
Cancer Res. 2014 Dec 15;74(24):7260-73. doi: 10.1158/0008-5472.CAN-14-0876. Epub 2014 Oct 21.
10
Production of Myxoma virus gateway entry and expression libraries and validation of viral protein expression.黏液瘤病毒网关入门和表达文库的构建及病毒蛋白表达的验证
Curr Protoc Microbiol. 2011 May;Chapter 14:Unit 14A.2. doi: 10.1002/9780471729259.mc14a02s21.
引用本文的文献
1
A Replication-Defective Myxoma Virus Inducing Pro-Inflammatory Responses as Monotherapy and an Adjuvant to Chemo- and DC Immuno-Therapy for Ovarian Cancer.一种复制缺陷型黏液瘤病毒，作为单一疗法及化疗和树突状细胞免疫疗法治疗卵巢癌的佐剂，可诱导促炎反应。
Viruses. 2025 Jul 29;17(8):1058. doi: 10.3390/v17081058.
2
Prospects for the use of viral proteins for the construction of chimeric toxins.病毒蛋白在嵌合毒素构建中的应用前景。
Arch Virol. 2024 Sep 26;169(10):208. doi: 10.1007/s00705-024-06139-8.
3
Cowpox Viruses: A Zoo Full of Viral Diversity and Lurking Threats.牛痘病毒：病毒多样性的动物园和潜伏的威胁。
Biomolecules. 2023 Feb 8;13(2):325. doi: 10.3390/biom13020325.
4
Poxvirus-driven human diseases and emerging therapeutics.痘病毒引发的人类疾病及新兴疗法。
Ther Adv Infect Dis. 2022 Nov 14;9:20499361221136751. doi: 10.1177/20499361221136751. eCollection 2022 Jan-Dec.
5
Progress on Poxvirus E3 Ubiquitin Ligases and Adaptor Proteins.痘病毒 E3 泛素连接酶和衔接蛋白的研究进展。
Front Immunol. 2021 Dec 9;12:740223. doi: 10.3389/fimmu.2021.740223. eCollection 2021.
6
Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma.载有黏液瘤病毒的间充质干细胞在小鼠肺黑色素瘤实验性溶瘤治疗中的应用
Mol Ther Oncolytics. 2020 Jul 6;18:335-350. doi: 10.1016/j.omto.2020.07.003. eCollection 2020 Sep 25.
7
Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways.黏液瘤病毒编码的宿主范围蛋白M029：一种靶向多种宿主抗病毒和固有免疫途径的多功能拮抗剂。
Vaccines (Basel). 2020 May 23;8(2):244. doi: 10.3390/vaccines8020244.
8
Oncolytic Virotherapy with Myxoma Virus.黏液瘤病毒溶瘤病毒疗法
J Clin Med. 2020 Jan 8;9(1):171. doi: 10.3390/jcm9010171.
9
Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.痘病毒作为基因治疗载体：构建表达治疗性转基因的痘病毒载体
Methods Mol Biol. 2019;1937:189-209. doi: 10.1007/978-1-4939-9065-8_11.
10
Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells.鉴定宿主 DEAD-box RNA 解旋酶，调控溶瘤性马痘病毒在人癌细胞中的细胞趋向性。
Sci Rep. 2017 Nov 16;7(1):15710. doi: 10.1038/s41598-017-15941-1.
本文引用的文献
1
Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.抑制供体组织中趋化因子-糖胺聚糖的相互作用可减少小鼠同种异体移植血管病和移植物排斥反应。
PLoS One. 2010 May 6;5(5):e10510. doi: 10.1371/journal.pone.0010510.
2
A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history.痘病毒 Bcl-2 样基因家族参与宿主免疫反应的调控：序列相似性和进化历史。
Virol J. 2010 Mar 15;7:59. doi: 10.1186/1743-422X-7-59.
3
Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.用黏液瘤病毒清除白血病造血干/祖细胞中的肿瘤病毒。
Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):169-75. doi: 10.1016/j.cytogfr.2010.02.010. Epub 2010 Mar 7.
4
Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.纤溶酶原病毒溶瘤疗法治疗免疫活性动物模型中的神经胶质瘤：优化给药途径和与雷帕霉素的协同作用。
Cancer Res. 2010 Jan 15;70(2):598-608. doi: 10.1158/0008-5472.CAN-09-1510. Epub 2010 Jan 12.
5
Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells.黏液瘤病毒靶向原发性人类白血病干细胞和祖细胞，同时不影响正常造血干细胞和祖细胞。
Leukemia. 2009 Dec;23(12):2313-7. doi: 10.1038/leu.2009.219. Epub 2009 Oct 29.
6
Co-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013.黏液瘤病毒含pyrin结构域蛋白M013对核因子κB和炎性小体介导的炎症反应的共同调节
PLoS Pathog. 2009 Oct;5(10):e1000635. doi: 10.1371/journal.ppat.1000635. Epub 2009 Oct 23.
7
Toll-like receptor signaling in cell proliferation and survival. toll 样受体信号转导在细胞增殖和存活中的作用。
Cytokine. 2010 Jan;49(1):1-9. doi: 10.1016/j.cyto.2009.08.010. Epub 2009 Sep 22.
8
Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-beta.人类癌细胞已经特异性地丧失了诱导由肿瘤坏死因子加β干扰素所引发的协同状态的能力。
Cytokine. 2009 Sep;47(3):199-205. doi: 10.1016/j.cyto.2009.06.006. Epub 2009 Jul 28.
9
Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200).黏液瘤病毒M141蛋白（vCD200）对巨噬细胞激活的抑制作用
J Virol. 2009 Sep;83(18):9602-7. doi: 10.1128/JVI.01078-09. Epub 2009 Jul 1.
10
Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbits.黏液瘤病毒M130R是兔致命性黏液瘤病所需的一种新型毒力因子。
Virus Res. 2009 Sep;144(1-2):258-65. doi: 10.1016/j.virusres.2009.05.009. Epub 2009 May 27.
Zotero 插件